What is Ferriprox®?
Ferriprox® (deferiprone) is an oral iron chelator. Ferriprox® is
indicated for the treatment of iron overload in patients with
thalassemia major when deferoxamine therapy is contraindicated or
inadequate.
Ferriprox® tablets first obtained marketing approval from The European
Medicines Agency (EMEA) in August 1999. It is now approved in 58
countries and is under review by local regulatory authorities in
many other jurisdictions. It is estimated that thousands of individuals
with iron overload are being treated with Ferriprox. Recently, the
EMEA has also approved Ferriprox® 100 mg/mL oral solution..
|
